# A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease

> **NCT01075763** · PHASE2 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 42 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Interferon beta-1a
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01075763
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01075763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01075763, "A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01075763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*